Name: Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
SKU: PX-TA1067
Availability: InStock

Free sample request
Secured Payment Methods
Engaged for the Environment

Size	100ug, 1MG
Isotype	(scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
Brand	ProteoGenix
Product type	Primary Antibodies
Clonality	Monoclonal Antibody
Expression system	Mammalian cells
Applications	Elisa, WB

Primary Antibodies ELISA WB Therapeutic Antibodies Cancer Immunology

Product name	Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source	CAS 853426-35-4
Species	Mus musculus
Expression system	Mammalian
Molecular weight	54.1kDa
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery lead time in business days	3-5 days if in stock; 3-5 weeks if production needed
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Aliases /Synonyms	Blinatumomab,AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3,CD19, CD3E,anti-CD19, CD3E
Reference	PX-TA1067
Note	For research use only. Not suitable for human use.
Isotype	(scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
Clonality	Monoclonal Antibody

Description of Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody

Blinatumomab is a monoclonal antibody constructed by BiTE (bispecific T cell engagers), which is used to treat relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) with negative Philadelphia chromosome. Blinatumomab is available as a drug under the Blincyto™ brand.

Datasheet Download

MSDS Download

Publication

Park AK, Monroy I, Ren Y, Lu C, Chaurasiya S, Valencia H, et al. Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. Journal for ImmunoTherapy of Cancer. 2025;13:e011051. https://doi.org/10.1136/jitc-2024-011051

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Price and Availability

Size

Clear

GET A QUOTE NOW

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us

CD19 Protein – Human CD19 recombinant protein

PX-P4004 250$

View product

Antigen

CD3E Recombinant Protein

PX-P4075 500$

View product

Antigen

CD19 Recombinant Protein

PX-P4077 500$

View product

Contact us

Send us a message from the form below

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

Description of Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody

REVIEW YOUR PRODUCT

CD19 Protein – Human CD19 recombinant protein

CD3E Recombinant Protein

CD19 Recombinant Protein

Contact us

Cart (0 Items)